| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/02/2011 | CN101983066A Ester-based peptide prodrugs |
| 03/02/2011 | CN101982458A 3-amino-3-arylpropionic acid and preparation method thereof |
| 03/02/2011 | CN101982198A Perfusion medicinal oil for treating hysteritis of cow and preparation method thereof |
| 03/02/2011 | CN101982197A Plukenetia volubilis polypeptide oral liquid |
| 03/01/2011 | US7899527 Treatment of conditions through modulation of the autonomic nervous system during at least one predetermined menstrual cycle phase |
| 03/01/2011 | US7897842 GnTIII expression in plants |
| 03/01/2011 | US7897757 for treating, preventing, inhibiting, or reducing obesity, insulin resistance, diabetes and any other disease, trait, or condition that is related to or will respond to the levels of PTP-1B in a cell or tissue |
| 03/01/2011 | US7897753 RNA interference mediated inhibition of XIAP gene expression using short interfering nucleic acid (siNA) |
| 03/01/2011 | US7897752 RNA interference mediated inhibition of telomerase gene expression using short interfering nucleic acid (siNA) |
| 03/01/2011 | US7897740 Secreted protein called 36P6D5 characteristic of tumors |
| 03/01/2011 | US7897732 Useful in methods for the induction of bone, cartilage and tissue formation, growth and development of the endometrium and in the acceleration of wound healing |
| 03/01/2011 | US7897731 Corticotropin releasing factor 2 receptor agonists |
| 03/01/2011 | US7897729 Polymeric immunoglobulin fusion proteins that target low affinity FcγReceptors |
| 03/01/2011 | US7897728 Hydrolyzing gelatin by contacting a gelatine with one or more proteolytic enzyme having endopeptidase activity and contacting the product with one or more proteolytic enzymes having exopeptidase activity; average viscosity of 10 to 15 cP; improved crosslinking and dissolution properties. |
| 03/01/2011 | US7897727 Bioactive peptide for cell adhesion |
| 03/01/2011 | US7897723 ErbB receptor-derived peptide fragments |
| 03/01/2011 | US7897722 Composition of bone formation with PHSRN-RGD containing oligopeptide |
| 03/01/2011 | US7897721 Cyclic peptide compositions for treatment of sexual dysfunction |
| 03/01/2011 | US7897647 Useful in extending the in vivo circulating life of biologically active materials; bicine linker allows for the manipulation of the hydrolysis rate of the prodrug, thereby releasing the native entities at various rates in vivo as well as in vitro |
| 03/01/2011 | US7897633 Neuronal disorders such as Alzheimer's disease, Down Syndrome, Parkinson disease, Chorea Huntington, pathogenic psychotic conditions, schizophrenia, impaired food intake, sleep-wakefulness, impaired homeostatic regulation of energy metabolism, impaired autonomic function; alcoholism |
| 03/01/2011 | US7897590 Methods to mobilize progenitor/stem cells |
| 03/01/2011 | US7897588 Agents and methods for enhancing bone formation |
| 03/01/2011 | US7897578 Peptides with anti-proliferative activity |
| 03/01/2011 | US7897577 Reconstituted surfactants having improved properties |
| 03/01/2011 | US7897575 Treatment and prevention of vascular dementia |
| 03/01/2011 | US7897574 Pharmaceutical composition for treating haemorrhagic shock and its consecutive symptoms |
| 03/01/2011 | US7897573 Selective VPAC2 receptor peptide agonists |
| 03/01/2011 | US7897572 Theraputic methods for type I diabetes |
| 03/01/2011 | US7897571 Recombinant lubricin molecules and uses thereof |
| 03/01/2011 | US7897570 EPH gene expression inhibition to facilitate tissue repair arising from disease or injuries of the nervous system; treatment of spinal cord injury as well as other central nervous system diseases such as Alzheimer's disease, Parkinson's disease and multiple sclerosis |
| 03/01/2011 | US7897569 Use of HMGB fragments as anti-inflammatory agents |
| 03/01/2011 | US7897568 Compositions for treatment of cancer |
| 03/01/2011 | US7897567 Methods of protecting against radiation damage using alpha thymosin |
| 03/01/2011 | US7897566 Analogues of GLP-1 |
| 03/01/2011 | US7897565 Compositions for HCV treatment |
| 03/01/2011 | US7897564 Flowable carrier matrix and methods for delivering to a patient |
| 03/01/2011 | US7897563 Use of oligomers and polymers for drug solubilization, stabilization, and delivery |
| 03/01/2011 | US7897562 Apoptosis-inducing agent and method for inducing apoptosis |
| 03/01/2011 | US7897561 complement inhibitor; VCP vaccinia virus complement control protein |
| 03/01/2011 | US7897560 Plasma protein affinity tags |
| 03/01/2011 | US7897387 Fungal cell wall synthesis gene |
| 03/01/2011 | US7897371 Using protein kinase inhibitors to treat and prevent glycogen metabolism defects and cell proliferative disorders |
| 03/01/2011 | US7897351 Peptides and antibodies to MUC 1 proteins |
| 03/01/2011 | US7897346 Polyamide nucleic acid derivatives and agents, and processes for preparing them |
| 03/01/2011 | US7897334 Detecting profilaggrin alleles; natural moisturising factors (NMF); erythema; cosmetics; antiinflammatory agents |
| 03/01/2011 | US7897328 Blood group antigens of different types for diagnostic and therapeutic applications |
| 03/01/2011 | US7897180 Enamel matrix protein composition for treatment of systemic inflammatory response |
| 03/01/2011 | US7897174 Formulation comprising bioactive agents and method of using same |
| 03/01/2011 | US7897165 Covalent binding of a hydrogel to an extracellular matrix; primed extracellular matrix comprises tyrosyl radicals, polymerizable agent is an acrylate; tissue repair, delivery of drugs or cells |
| 03/01/2011 | US7897164 Compositions and methods for nucleus pulposus regeneration |
| 03/01/2011 | US7897163 Bone graft and scaffolding materials immobilized with osteogenesis enhancing peptides on the surface |
| 03/01/2011 | US7897160 Conjugated fatty acid based emulsion and methods for preparing and using same |
| 03/01/2011 | US7897158 Recombinant toxin fragments |
| 03/01/2011 | US7897157 Polypeptides with a functional binding domain, translocation domain, a therapeutic domain and a non-native protease cleavage site for cleavage in vitro following expression as a single chain; efficient, less dangerous production method; botulinum neurotoxins targeted to specific cell types |
| 03/01/2011 | US7897152 Viral chemokine-antigen fusion proteins |
| 03/01/2011 | US7897147 Treatment of premenstrual disorders |
| 03/01/2011 | US7897145 Methods for the treatment of renal failure |
| 03/01/2011 | CA2469154C Cytotoxic protein and utilization thereof |
| 03/01/2011 | CA2368618C Method of enhancing the efficacy of anti-tumor agents |
| 03/01/2011 | CA2348954C A pharmaceutical composition for treating immune diseases |
| 03/01/2011 | CA2339331C Expression and export of angiogenesis inhibitors as immunofusins |
| 03/01/2011 | CA2323525C Therapeutic and diagnostic applications based on the role of the cxcr-4 gene in tumorigenesis |
| 03/01/2011 | CA2301709C Epitope-bearing major histocompatibility complex class ii element/immunoglobulin chimeric molecules |
| 02/24/2011 | WO2011022725A2 Mimotopes of hiv and uses thereof |
| 02/24/2011 | WO2011022657A1 Purification of vwf for increased removal of non-lipid enveloped viruses |
| 02/24/2011 | WO2011022491A1 Cysteine for physiological injection |
| 02/24/2011 | WO2011022462A2 Neural regeneration |
| 02/24/2011 | WO2011022396A1 Lipid construct for delivery of insulin to a mammal |
| 02/24/2011 | WO2011022389A1 Compositions and methods for wound healing |
| 02/24/2011 | WO2011022357A2 Fast acting snare-cleaving enzymes |
| 02/24/2011 | WO2011022334A1 Use of nkg2d inhibitors for treating cardiovascular and metabolic diseases, such as type 2 diabetes |
| 02/24/2011 | WO2011022071A2 Cardiac compositions |
| 02/24/2011 | WO2011022070A2 Perivascular stem cell composition for bone |
| 02/24/2011 | WO2011022056A2 PEPTIDE MODULATORS OF THE δPKC INTERACTION WITH THE D SUBUNIT OF F1FO ATP SYNTHASE/ATPASE AND USES THEREOF |
| 02/24/2011 | WO2011022045A2 Apparatus and process for generating and harvesting adult stem cells and fluid associated with it from skin and omentum for medical, cosmetic, and veterinary use |
| 02/24/2011 | WO2011021916A2 Use of egf-like domain of heregulin beta 1 peptide |
| 02/24/2011 | WO2011021833A2 Composition for preventing or treating inflammation |
| 02/24/2011 | WO2011021832A2 Composition for preventing or treating a spinal cord injury |
| 02/24/2011 | WO2011021524A1 Peptides inducing adhesive property of lactic acid bacterium and use of same |
| 02/24/2011 | WO2011021508A1 Marker for predicting therapeutic effect on hepatitis c, method for predicting therapeutic effect on hepatitis c, and prophylaxis or therapeutic agent for hepatitis c |
| 02/24/2011 | WO2011021166A1 Meganuclease variants cleaving a dna target sequence from the human lysosomal acid alpha-glucosidase gene and uses thereof |
| 02/24/2011 | WO2011021062A1 Meganuclease variants cleaving a dna target sequence from the human lysosomal acid alpha-glucosidase gene and uses thereof |
| 02/24/2011 | WO2011020913A2 Cyclodepsipeptide antiviral compounds |
| 02/24/2011 | WO2011020866A2 Albumin fused coagulation factors for non-intravenous administration in the therapy and prophylactic treatment of bleeding disorders |
| 02/24/2011 | WO2011020865A1 Apolipoprotein l- i variants and their use |
| 02/24/2011 | WO2011020497A1 C-terminal mutant of apolipoprotein l-i and its therapeutical or prophylactic use |
| 02/24/2011 | WO2011020320A1 Homodimer of insulinotropic peptide analogues and method for preparation thereof and use thereof |
| 02/24/2011 | WO2011020319A1 Fusion protein regulating plasma glucose and lipid, its preparation method and use |
| 02/24/2011 | WO2011020133A1 Use of mimotopes of alpha-synuclein epitopes for treating lewy body diseases |
| 02/24/2011 | WO2011002834A3 Compositions and methods for diagnosis and treatment of type 1 diabetes |
| 02/24/2011 | WO2010149792A3 Antimicrobial agents |
| 02/24/2011 | WO2010146062A3 Novel anti-nematode therapies targetting strm-1 |
| 02/24/2011 | WO2010136508A3 Stem cell targeting |
| 02/24/2011 | WO2010133834A3 Fviii-derived peptides |
| 02/24/2011 | WO2010123930A3 Chemosensory receptor ligand-based therapies |
| 02/24/2011 | WO2010115172A3 Antigenic peptide of hsv-2 and methods for using same |
| 02/24/2011 | WO2010111525A3 Treatment of carpal tunnel syndrome by injection of the flexor retinaculum |
| 02/24/2011 | WO2010111443A3 Omentum as a source of stromal/stem cells and medical treatments using omentum stromal/stem cells |
| 02/24/2011 | WO2010107909A3 Methods and compositions for the detection of cancer |
| 02/24/2011 | WO2010080769A4 Chemotherapeutic methods and compositions |